Atlas Capital Advisors LLC Eli Lilly & CO Transaction History

Atlas Capital Advisors LLC

$640 Billion
Q1 2024

A detailed history of Atlas Capital Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 2,400 shares of LLY stock, worth $2.16 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

2,400

Previous 2,482 3.3%

Holding current value

$2.16 Million

Previous $1.45 Billion 29.05%

% of portfolio

0.29%

Previous 0.21%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $48,560 - $64,966	-82 Reduced 3.3%	2,400 $1.87 Billion
Q4 2023 Feb 15, 2024	SELL	$525.19 - $619.13 $3,676 - $4,333	-7 Reduced 0.28%	2,482 $1.45 Billion
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $315,157 - $434,492	-725 Reduced 22.56%	2,489 $1.34 Billion
Q2 2023 Aug 15, 2023	SELL	$350.74 - $468.98 $37,178 - $49,711	-106 Reduced 3.19%	3,214 $1.51 Billion
Q1 2023 May 16, 2023	SELL	$310.63 - $364.82 $82,006 - $96,312	-264 Reduced 7.37%	3,320 $1.14 Billion

Q4 2022 Feb 15, 2023	SELL	$321.55 - $374.67 $55,949 - $65,192	-174 Reduced 4.63%	3,584 $1.31 Billion
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $35,874 - $40,882	121 Added 3.33%	3,758 $1.22 Billion
Q2 2022 Aug 16, 2022	SELL	$278.73 - $327.27 $248,905 - $292,252	-893 Reduced 19.71%	3,637 $1.18 Billion
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $483,696 - $601,111	2,061 Added 83.48%	4,530 $1.3 Billion
Q4 2021 Feb 01, 2022	SELL	$224.85 - $279.04 $779,779 - $967,710	-3,468 Reduced 58.41%	2,469 $682 Million
Q3 2021 Oct 28, 2021	BUY	$221.6 - $272.71 $1.29 Million - $1.59 Million	5,830 Added 5448.6%	5,937 $1.37 Million
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $7,583 - $9,808	42 Added 64.62%	107 $24,000
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $10,680 - $13,826	65 New	65 $12,000

Others Institutions Holding LLY

# of Institutions

3,722

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $853B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Account

Atlas Capital Advisors LLC Eli Lilly & CO Transaction History